31.0% Below Target

The consensus Wall Street price target for CBZ is $41.33, representing 31.0% upside from the current price of $31.56. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

CBZ has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $41.33 implies 31.0% upside from current levels.

With a forward P/E of 7.7625x, CBZ trades at a relatively low valuation. The consensus target of $41.33 implies 31.0% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $45 for CBZ, while the most conservative target is $37. The consensus of $41.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $79 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CBZ is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CBZ stock forecast based on 2 Wall Street analysts shows a consensus price target of $41.33, with estimates ranging from $37 (bear case) to $45 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $60, with bear/bull scenarios of $38/$79.

Our quantitative valuation model calculates CBZ's fair value at $60 (base case), with a bear case of $38 and bull case of $79. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.

CBZ trades at a forward P/E ratio of 7.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on CBZ, with a "Buy" consensus rating and $41.33 price target (31.0% upside). 1 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CBZ analyst price targets range from $37 to $45, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $41.33 consensus represents the middle ground. Our model's $38-$79 range provides an independent fundamental perspective.